Docket #: S21-466
Methods for isolating neural stem and progenitor cells from the developing human brain
Researchers at Stanford have developed a novel method for the isolation of neural stem and progenitor cells (NSPCs). The ability to isolate and purify distinct NSPC types is crucial for scientific research studying neurodevelopment and developing therapeutics for neural regeneration. This novel method includes dissociation of brain tissue, staining with fluorescent antibodies, and isolation of cell types using fluorescence-activated cell sorting (FACS) based on the expression of various cell surface markers. Using different surface marker combinations, the method can isolate nine distinct NSPC types, including oligodendrocyte precursor cells (OPCs) and pre-OPCs, as well as excitatory and inhibitory neurons. The method purity for isolating NSPC types is superior to existing cell isolation methods and was verified using single-cell RNA sequencing and sorting. Isolated cells were functionally validated using in vitro and in vivo models. Successfully isolated NSPCs can be grown as neurospheres, used in preclinical and clinical applications such as disease modeling and drug screening, and/or banked for future use.
Stage of Development:
Prototype
Figure:
Applications
- Can be used for the isolation of NSPCs
- Isolated NSPCs can be:
- Grown as neurospheres
- Used in preclinical and clinical applications such as disease modeling and drug screening
- Banked for future use
Advantages
- Improved pure population yield of neural stem cells compared to previous methods
- Improved neurosphere growing proficiency from isolated NSPCs (1 in 5) compared to previous methods (1 in 23)
- Novel sorting method, with many of the markers used never previously described for this application
Publications
Related Links
Similar Technologies
-
Quantifiable heavy metal detection in immune cells S21-240Quantifiable heavy metal detection in immune cells
-
Biomarkers for Ovarian Cancer Diagnostics Prognostics as a Guide to Individualized Therapies S15-338Biomarkers for Ovarian Cancer Diagnostics Prognostics as a Guide to Individualized Therapies
-
Microfluidics device for high-throughput liquid biopsy and other cellular analyses S17-169Microfluidics device for high-throughput liquid biopsy and other cellular analyses